Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial

被引：0
|
作者：
Lachmann, Helen [1 ,2 ]
Lauwerys, Bernard [3 ]
Miettunen, Paivi [4 ]
Kallinich, Tilmann [5 ]
Jansson, Annette [6 ]
Rosner, Itzhak
Manna, Raffaele [7 ]
Murias, Saramaria [8 ]
Savic, Sinisa [9 ]
Smeets, Serge [10 ]
De Benedetti, Fabrizio [11 ]
Simon, Anna [12 ]
机构：
[1] Royal Free Hosp, London, England
[2] UCL, London, England
[3] Catholic Univ Louvain, Brussels, Brussels Hoofds, Belgium
[4] Alberta Childrens Prov Gen Hosp, Calgary, ON, Canada
[5] Charite, Berlin, Germany
[6] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany
[7] Univ Cattolica Sacro Cuore, Rome, Lazio, Italy
[8] Univ Hosp La Paz, Madrid, Spain
[9] St James Univ Hosp, Leeds, W Yorkshire, England
[10] Novartis, Amsterdam, Netherlands
[11] Bambino Gesu Pediat Hosp, Rome, Italy
[12] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0802
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial
    Younossi, Zobair M.
    Stepanova, Maria
    Feld, Jordan
    Zeuzem, Stefan
    Jacobson, Ira
    Agarwal, Kosh
    Hezode, Christophe
    Nader, Fatema
    Henry, Linda
    Hunt, Sharon
    JOURNAL OF HEPATOLOGY, 2016, 65 (01) : 33 - 39
  • [22] Treatment with bulevirtide improves patient-reported outcomes in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks
    Buti, Maria
    Wedemeyer, Heiner
    Aleman, Soo
    Chulanov, Vladimir
    Viacheslav, Morozov
    Sagalova, Olga
    Stepanova, Tatyana
    Gish, Robert G.
    Lloyd, Andrew
    Kaushik, Ankita
    Suri, Vithika
    Manuilov, Dmitry
    Osinusi, Anu
    Flaherty, John F.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2022, 77 : S103 - S103
  • [23] Patient-reported outcomes from the phase 3 ADMIRAL trial in patients with FLT3-mutated relapsed/refractory AML
    Ritchie, Ellen K.
    Cella, David
    Fabbiano, Francesco
    Pigneux, Arnaud
    Kanda, Yoshinobu
    Ivanescu, Cristina
    Pandya, Bhavik J.
    Shah, Manasee V. V.
    LEUKEMIA & LYMPHOMA, 2023, 64 (05) : 938 - 950
  • [24] Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial
    Strand, Vibeke
    Gossec, Laure
    Coates, Laura C.
    Ogdie, Alexis
    Choi, Jiyoon
    Becker, Brandon
    Zhuo, Joe
    Lehman, Thomas
    Nowak, Miroslawa
    Elegbe, Ayanbola
    Mease, Philip J.
    Deodhar, Atul
    ARTHRITIS CARE & RESEARCH, 2024, 76 (08) : 1139 - 1148
  • [25] Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
    Siena, S.
    Peeters, M.
    Van Cutsem, E.
    Humblet, Y.
    Conte, P.
    Bajetta, E.
    Comandini, D.
    Bodoky, G.
    Van Hazel, G.
    Salek, T.
    Wolf, M.
    Devercelli, G.
    Woolley, M.
    Amado, R. G.
    BRITISH JOURNAL OF CANCER, 2007, 97 (11) : 1469 - 1474
  • [26] Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
    S Siena
    M Peeters
    E Van Cutsem
    Y Humblet
    P Conte
    E Bajetta
    D Comandini
    G Bodoky
    G Van Hazel
    T Salek
    M Wolf
    G Devercelli
    M Woolley
    R G Amado
    British Journal of Cancer, 2007, 97 : 1469 - 1474
  • [27] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    Strand, V.
    de Vlam, K.
    Covarrubias-Cobos, J. A.
    Mease, P. J.
    Gladman, D. D.
    Hendrikx, T.
    Kudlacz, E.
    Graham, D.
    Wu, J.
    Chen, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1335 - 1336
  • [28] Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: Results from two phase 3 studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose
    Mease, Philip
    Gladman, Dafna
    Hendrikx, Thijs
    Graham, Daniela
    Wu, Joseph
    Chen, Linda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB109 - AB109
  • [29] Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose A.
    Mease, Philip J.
    Gladman, Dafna D.
    Hendrikx, Thijs
    Kudlacz, Elizabeth
    Graham, Daniela
    Wu, Joseph
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial
    Strand, Vibeke
    Kaeley, Gurjit S.
    Bergman, Martin J.
    Gladman, Dafna D.
    Coates, Laura C.
    Sherif, Bintu
    Hur, Peter
    Parikh, Bhumik
    Gilloteau, Isabelle
    Mease, Philip J.
    LANCET RHEUMATOLOGY, 2022, 4 (03): : E208 - E219
12345